A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. (Q51302141)
Jump to navigation
Jump to search
scientific article published on 25 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. |
scientific article published on 25 April 2015 |
Statements
1 reference
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. (English)
1 reference
1 reference
L Pacifico
1 reference
M Di Martino
1 reference
P Versacci
1 reference
G Andreoli
1 reference
L M Silvestri
1 reference
C Chiesa
1 reference
25 April 2015
1 reference
25
1 reference
734-741
1 reference
8
1 reference
Identifiers
1 reference